AlphaQuest LLC Boosts Stock Position in Intuitive Surgical, Inc. $ISRG

AlphaQuest LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 519.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,839 shares of the medical equipment provider’s stock after purchasing an additional 1,542 shares during the quarter. AlphaQuest LLC’s holdings in Intuitive Surgical were worth $999,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Ground Swell Capital LLC purchased a new position in shares of Intuitive Surgical in the second quarter valued at $453,000. Blue Sky Capital Consultants Group Inc. boosted its position in Intuitive Surgical by 35.2% in the 2nd quarter. Blue Sky Capital Consultants Group Inc. now owns 7,713 shares of the medical equipment provider’s stock valued at $4,191,000 after buying an additional 2,009 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in Intuitive Surgical by 8,900.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 180 shares of the medical equipment provider’s stock valued at $98,000 after buying an additional 178 shares during the period. Asset Management One Co. Ltd. boosted its position in Intuitive Surgical by 0.8% in the 2nd quarter. Asset Management One Co. Ltd. now owns 193,600 shares of the medical equipment provider’s stock valued at $105,204,000 after buying an additional 1,602 shares during the period. Finally, R Squared Ltd boosted its position in Intuitive Surgical by 267.5% in the 2nd quarter. R Squared Ltd now owns 2,793 shares of the medical equipment provider’s stock valued at $1,518,000 after buying an additional 2,033 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 40,724 shares of company stock valued at $19,500,332. 0.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Robert W. Baird set a $655.00 price objective on Intuitive Surgical in a report on Wednesday. Rothschild & Co Redburn boosted their price target on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday. Sanford C. Bernstein restated an “outperform” rating and set a $685.00 price target on shares of Intuitive Surgical in a research note on Tuesday. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Daiwa Capital Markets upped their target price on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $602.32.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $546.51 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm has a market capitalization of $195.91 billion, a price-to-earnings ratio of 72.29, a price-to-earnings-growth ratio of 5.45 and a beta of 1.61. The business’s 50 day moving average price is $458.09 and its 200-day moving average price is $497.29.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the firm posted $1.84 EPS. The business’s revenue was up 22.9% on a year-over-year basis. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.